HitGen Inc. offers generic pharma services. The Company provides deoxyribonucleic acid encoded libraries (DEL) rating, DEL selecting, chemical synthesis, and other services. HitGen provides its services throughout China.

Chengdu Leading Drug Development Co., Ltd. 2020 Annual Results Express Announcement (成都先导药物开发股份有限公司2020年年度业绩快报公告)

Reply To The Inquiry Letter Regarding Abnormal Fluctuations In Stock Trading Of Chengdu Leading Drug Development Co., Ltd. (关于成都先导药物开发股份有限公司股票交易异常波动问询函的回函)

Announcement Of Chengdu Leading Drug Development Co., Ltd. On The Progress And Completion Of The Acquisition Of 100% Equity Of Vernalis (R&D) Limited (成都先导药物开发股份有限公司关于收购Vernalis [R&D] Limited 100%股权进展暨交割完成的公告)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00